Page last updated: 2024-08-21

malondialdehyde and Gasser Syndrome

malondialdehyde has been researched along with Gasser Syndrome in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (44.44)	18.7374
1990's	2 (22.22)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albesa, I; Claudia, A; Gabriela, O; Jorge, EA; Soledad, BP; Virginia, A	1
Abrey-Recalde, MJ; Fernández, GC; Ferrarotti, NF; Gomez, SA; Isturiz, MA; Mejías, MP; Palermo, MS; Panek, CA; Repetto, MG; Vanzulli, S	1
Hyvärinen, S; Jokela, R; Jokiranta, TS; Uchida, K; Varjosalo, M	1
Coppe, D; Spitzer, RE; Stuart, MJ	1
Harlan, JM	1
Campisi, A; Di Giacomo, C; Garozzo, R; Li Volti, S; Mollica, F; Vanella, A	1
Bagirova, NI; Balashova, TS; Kubatiev, AA; Tebloeva, LT; Zverev, DV	1
Alade, SL; Brown, RE; Evans, BJ; Knight, JA	1
Fong, JS; Kaplan, BS; Vedanarayanan, VV	1

Reviews

1 review(s) available for malondialdehyde and Gasser Syndrome

Article	Year
Thrombocytopenia due to non-immune platelet destruction. Clinics in haematology, 1983, Volume: 12, Issue:1 Topics: Bacterial Infections; Bleeding Time; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Bone Marrow Examination; Disseminated Intravascular Coagulation; Hemolytic-Uremic Syndrome; Humans; Malondialdehyde; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Surface Properties; Thrombin; Thrombocytopenia	1983

Article

Year

Thrombocytopenia due to non-immune platelet destruction.

Clinics in haematology, 1983, Volume: 12, Issue:1

Topics: Bacterial Infections; Bleeding Time; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Bone Marrow Examination; Disseminated Intravascular Coagulation; Hemolytic-Uremic Syndrome; Humans; Malondialdehyde; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Surface Properties; Thrombin; Thrombocytopenia

1983

Other Studies

8 other study(ies) available for malondialdehyde and Gasser Syndrome

Article	Year
Nitrosylation: an adverse factor in Uremic Hemolytic Syndrome. Antitoxin effect of Ziziphus mistol Griseb. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2013, Volume: 56 Topics: Advanced Oxidation Protein Products; Antioxidants; Antitoxins; Child; Hemolysin Proteins; Hemolytic-Uremic Syndrome; Humans; Lipid Metabolism; Malondialdehyde; Nitric Oxide; Oxidative Stress; Plant Extracts; Polyphenols; Reactive Oxygen Species; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Ziziphus	2013
The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome. Clinical and experimental immunology, 2013, Volume: 173, Issue:3 Topics: Acetylcysteine; Animals; Cysteine; Disease Models, Animal; Glutathione; Hemolytic-Uremic Syndrome; Lipid Peroxidation; Male; Malondialdehyde; Mice; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Shiga Toxin 2; Shiga-Toxigenic Escherichia coli	2013
Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome. The Journal of biological chemistry, 2014, Feb-14, Volume: 289, Issue:7 Topics: Amines; Animals; Atypical Hemolytic Uremic Syndrome; Binding Sites; Cattle; Complement Activation; Complement Factor H; Hemolytic-Uremic Syndrome; Humans; Malondialdehyde; Mutation; Oxidative Stress; Protein Processing, Post-Translational; Serum Albumin, Bovine	2014
Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome. Pediatrics, 1983, Volume: 71, Issue:1 Topics: Aspirin; Blood Platelets; Epoprostenol; Femoral Artery; Femoral Vein; Hemolytic-Uremic Syndrome; Humans; Infant; Male; Malondialdehyde; Platelet Count; Prostaglandin Endoperoxides; Prostaglandins	1983
Impaired antioxidant defense mechanisms in two children with hemolytic-uremic syndrome. Renal failure, 1993, Volume: 15, Issue:4 Topics: Catalase; Child, Preschool; Erythrocytes; Female; Free Radical Scavengers; Glucosephosphate Dehydrogenase; Glutathione Peroxidase; Glutathione Reductase; Hemolytic-Uremic Syndrome; Humans; Infant; Lipid Peroxidation; Male; Malondialdehyde; Superoxide Dismutase	1993
[Hemolytic uremic syndrome as a clinical manifestation of oxidative stress]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 1996, Issue:9 Topics: Catalase; Child, Preschool; Erythrocyte Membrane; Female; Free Radicals; Hemolytic-Uremic Syndrome; Humans; Infant; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Retrospective Studies; Spectrophotometry; Superoxide Dismutase; Vitamin E	1996
Serum lipoperoxidation products in an infant with hemolytic-uremic syndrome. Clinical chemistry, 1988, Volume: 34, Issue:11 Topics: Hemolytic-Uremic Syndrome; Humans; Infant; Lipid Peroxides; Male; Malondialdehyde	1988
Neutrophil function in an experimental model of hemolytic uremic syndrome. Pediatric research, 1987, Volume: 21, Issue:3 Topics: Animals; Blood Coagulation Factors; Cell Aggregation; Chemotaxis, Leukocyte; Endotoxins; Escherichia coli; Glucuronidase; Hemolytic-Uremic Syndrome; Kidney Cortex; Leukocyte Count; Male; Malondialdehyde; Neutrophils; Rabbits; Time Factors	1987